A National Cooperative Growth Study of Protropin.
Nearly 2000 hGH deficient patients have been enrolled in a study of Protropin and followed up for up to 1 year. This has provided valuable information on the character of this population and its response to therapy. Overall there was a predominance of males, with a disproportionate number of short mothers. The mean Protropin dose was 0.07 mg/kg, given three times/week. There was a significant dose-response relationship up to 0.125 mg/kg three times/week.
D002648:Child; D004305:Dose-Response Relationship, Drug; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy*; D013006:Growth Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000172:deficiency* / Q000627:therapeutic use; D006728:Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D019382:Human Growth Hormone; D006801:Humans; D008297:Male; D014481:United States
D006728:Hormones; D019382:Human Growth Hormone; D013006:Growth Hormone